Molecular targeting agents in the context of primary chemoradiation strategies.

Abstract

Demands for organ preservation and increasing knowledge in molecular tumor biology have lead to the development of molecular targeting agents. These substances have also been incorporated into concomitant and sequential chemoradiation protocols.

Bibliographical data

Original languageEnglish
Article number5
ISSN1043-3074
Publication statusPublished - 2013
pubmed 22267285